Applied DNA Sciences Inc (APDN)
0.60
-1.39
(-69.85%)
USD |
NASDAQ |
May 28, 16:00
0.619
+0.02
(+3.17%)
After-Hours: 20:00
Applied DNA Sciences Cash from Investing (Quarterly): -0.0148M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.0148M |
December 31, 2023 | 0.00 |
September 30, 2023 | -0.9247M |
June 30, 2023 | -0.1618M |
March 31, 2023 | -0.0543M |
December 31, 2022 | 0.045M |
September 30, 2022 | -0.2427M |
June 30, 2022 | -0.0767M |
March 31, 2022 | -0.0655M |
December 31, 2021 | -0.1047M |
September 30, 2021 | -0.9064M |
June 30, 2021 | -0.5027M |
March 31, 2021 | -0.81M |
December 31, 2020 | -0.3295M |
September 30, 2020 | -1.008M |
June 30, 2020 | -0.0114M |
March 31, 2020 | -0.0448M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.001M |
June 30, 2019 | -0.0045M |
March 31, 2019 | -0.0119M |
December 31, 2018 | -0.0521M |
September 30, 2018 | 0.0035M |
June 30, 2018 | -0.066M |
March 31, 2018 | -0.1552M |
Date | Value |
---|---|
December 31, 2017 | -0.0483M |
September 30, 2017 | -0.0341M |
June 30, 2017 | -0.0176M |
March 31, 2017 | -0.051M |
December 31, 2016 | -0.0426M |
September 30, 2016 | -0.1471M |
June 30, 2016 | -0.4724M |
March 31, 2016 | -0.0941M |
December 31, 2015 | -0.0661M |
September 30, 2015 | -1.679M |
June 30, 2015 | -0.2269M |
March 31, 2015 | -0.2021M |
December 31, 2014 | -0.0308M |
September 30, 2014 | -0.0201M |
June 30, 2014 | -0.0999M |
March 31, 2014 | -0.0151M |
December 31, 2013 | -0.0945M |
September 30, 2013 | -0.4231M |
June 30, 2013 | -0.7675M |
March 31, 2013 | -0.0301M |
December 31, 2012 | 0.00 |
September 30, 2012 | -0.097M |
June 30, 2012 | -0.0187M |
March 31, 2012 | -0.0471M |
December 31, 2011 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.008M
Minimum
Sep 2020
0.045M
Maximum
Dec 2022
-0.2608M
Average
-0.0711M
Median
Cash from Investing (Quarterly) Benchmarks
Fonar Corp | -0.289M |
XWELL Inc | -0.371M |
ProPhase Labs Inc | 2.435M |
Veracyte Inc | 2.878M |
OncoCyte Corp | -0.024M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -3.21M |
Cash from Financing (Quarterly) | 3.015M |
Free Cash Flow | -11.06M |
Free Cash Flow Per Share (Quarterly) | -3.701 |
Free Cash Flow to Equity (Quarterly) | -3.225M |
Free Cash Flow to Firm (Quarterly) | -3.225M |
Free Cash Flow Yield | -2.60K% |